NCT05570708

The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy Training

• Status: Enrolling By Invitation
• Phase: N/A
• Study type: Interventional
• Enrollment: 48 (estimated)
• Sponsor: Felix Mueller · Academic / Other
• Sex: All
• Age: 27 Years
• Healthy volunteers: Accepted

Summary

The study investigates two groups of participants of the SÄPT therapist's training starting in October 2022. The overall objective is to investigate the risks and benefits of personal experience (PE) with substance-induced altered states of consciousness for physicians or psychotherapists in the context of a training course for substance-assisted therapy. Specifically, the study aims to assess changes in therapeutic attitude and other factors important in interactions between patients and therapists (such as empathy and cognitive flexibility).

Conditions

• Personal Experience of Substance-assisted Therapy Using Psilocybin, MDMA, and LSD

Interventions

Type	Name	Description
DRUG	MDMA, LSD, psilocybin	* MDMA per os (2 x 100mg) in a group setting * LSD per os (75 and 150 mcg) in a 1:1 setting * Psilocybin per os (15 mg and 25 mg) in a group setting * Three study days are without drug administration: Participants experience the role of the therapist in a 1:1 setting

Timeline

• Start date: 2022-10-25
• Primary completion: 2029-06-01
• Completion: 2029-06-01
• First posted: 2022-10-07
• Last updated: 2025-04-14

Locations

1 site across 1 country: Switzerland